The short-term outcomes of Ticagrelor versus Clopidogrel in patients with myocardial infarctio

Phase 2

Recruiting

• Conditions: Acute myocardial infarction.; Other current complications following acute myocardial infarction; I23.8

• Registration Number: IRCT20180205038626N9
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

Age 18 years and older
Chest pain that lasts more than 20 minutes and no response to nitroglycerin
Patients with PCI were underwent PCI less than 12 hours from the onset of symptoms.
The ST segment rises more than 1 mm in at least two or more limb leads.
The ST segment is more than 2 mm high in two or more precordial leads.

Exclusion Criteria

Cardiogenic shock in the form of systolic blood pressure less than 90 to 60 mm Hg and did not respond to hydration therapy
Thrombolysis in the last 24 hours
Recent anticoagulant therapy or recent use of P2Y12 antagonist
Contraindications to aspirin, clopidogrel and ticagrelor
History of coronary artery bypass grafting in recent year
Patient dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thrombosis. Timepoint: 3 months later. Method of measurement: Clinical signs and laboratory tests.;Stroke. Timepoint: 3 months later. Method of measurement: CT scan.;Myocardial Infarction. Timepoint: 3 months later. Method of measurement: Electrocardiography, Echocardiography.

Secondary Outcome Measures

Name	Time	Method
Death. Timepoint: 3 months later. Method of measurement: Phone call with the patient.